ERBB2 and cancer: A clear shift in fluorescence intensity was observed for HER2+ cells (BT474 and SKOV3) versus the negative control cell line (MDA-MB-231), confirming that NM-02 was able to recognise cell-surface expressed HER2 from different cancer types (Fig 1b).